Effect of Venous Cannulation on the Incidence of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass
Effect of Venous Cannulation Technique on the Incidence of Post-operative Atrial Fibrillation in Patients Undergoing Elective Coronary Artery Bypass Grafting. A Pilot Randomized Controlled Trial.
1 other identifier
interventional
40
1 country
1
Brief Summary
Context Atrial fibrillation is the most frequent arrhythmia following coronary artery bypass grafting. POAF is associated with worse outcomes following CABG. In addition, recurrence of AF is associated with longer hospital stay and higher rate of neurological and renal complications compared to a single episode of AF Objective To estimate the proportion of eligible people who are willing to participate, number of participants who drop out of the trial and use the results of this study to inform a larger study. Study Design: Pilot randomized controlled trial. Patients will be blinded to the intervention. Participants: The study population will include 40 patients. Patients admitted to the Jewish General Hospital for elective coronary artery bypass grafting from May 2021 will be included in the study. Patients will be included if they were in sinus rhythm with a HR ≥50 bpm, undergoing on-pump coronary artery bypass grafting and hemodynamically stable. Patients will be excluded from the study if they meet any of the following criteria: Second or third degree heart block, LVEF \<35%, left atrial volume index ≥42 ml/m2, right atrial volume index \> 47 ml/m2, any degree of tricuspid regurgitation, any degree of right ventricular dysfunction, emergency or minimally invasive operation, concurrent valve operation, history of atrial fibrillation or previous cardiac surgery Study Interventions and Measures Patients will be randomly assigned to one of two treatment groups according to the venous cannulation technique used during surgery. Group A will undergo cavoatrial cannulation with a 2-stage venous cannula. Group B will undergo bicaval cannulation with snares. Similar surgical methods will be used in all treatment groups . The primary endpoint will be defined as any episode of atrial fibrillation in any participant lasting \>5 minutes in duration or any episode leading to hemodynamic compromise (SBP\<90 mmHg) or causing symptoms (angina or dyspnea). Atrial fibrillation will be diagnosed using telemetry and a 12-lead ECG. Patients will be followed up in 1 month with a 12-lead ECG to determine their rhythm. The secondary endpoints are the development of RV dysfunction, tricuspid regurgitation and any increase in left atrial volume index as detected by post-operative transthoracic echocardiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable atrial-fibrillation
Started Jul 2022
Shorter than P25 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2020
CompletedFirst Posted
Study publicly available on registry
November 24, 2020
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedApril 9, 2024
April 1, 2024
1.6 years
November 11, 2020
April 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Atrial fibrillation
Number of participants who develop atrial fibrillation that requires treatment. Atrial fibrillation will be defined as any episode in any participant lasting \>5 minutes in duration or any episode leading to hemodynamic compromise (SBP\<90 mmHg) or causing symptoms (angina or dyspnea).
During hospital admission and clinic visit at 30 days from hospital discharge date.
Secondary Outcomes (3)
Tricuspid regurgitation
on transthoracic echocardiogram performed on day 2-5 post-operatively
Right ventricular dysfunction
on transthoracic echocardiogram performed on day 2-5 post-operatively
Increase in Left atrial index
on transthoracic echocardiogram performed on day 2-5 post-operatively
Study Arms (2)
Cavoatrial cannulation
ACTIVE COMPARATORCannulation of the atrium with 2-stage venous cannula.
Bicaval cannulation
EXPERIMENTALCannulating the superior and inferior vena cavae with separate cannulas, inserted through 2 separate incisions in the right artium going into the superior and inferior vena cavae. No slush added. This technique is used in Right heart procedure (Pulmonic and tricuspid valve) and mitral valve procedures. This technique is not routinely used in CABG operations.
Interventions
Cannulation of SVC and IVC through right atrium in patients undergoing CABG. with snares applied
Cannulating the right atrium and Inferior vena cava with a 2-stage cannula
Eligibility Criteria
You may qualify if:
- Patients admitted for coronary artery bypass grafting under the care of the principal investigator at the Jewish General Hospital during the study period will be included if they meet all the following criteria:
- Age \>18 years
- Sinus rhythm with HR \>50bpm
- Scheduled to undergo isolated elective on-pump CABG
- Hemodynamically stable.
You may not qualify if:
- Patients will be excluded from the study if they meet any of the following criteria:
- Second or third degree heart block
- LVEF \<35%
- left atrial volume index ≥42 ml/m2
- right atrial volume index \> 47 ml/m2
- any degree of tricuspid regurgitation
- any degree of right ventricular dysfunction
- emergency or minimally invasive operation
- concurrent valve operation
- history of atrial fibrillation
- previous cardiac surgery
- previous catheter ablation for atrial fibrillation
- pre-operative use of class I or III anti-arrhythmics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital.
Montreal, Quebec, H3T 1E2, Canada
Related Publications (27)
Maesen B, Nijs J, Maessen J, Allessie M, Schotten U. Post-operative atrial fibrillation: a maze of mechanisms. Europace. 2012 Feb;14(2):159-74. doi: 10.1093/europace/eur208. Epub 2011 Aug 6.
PMID: 21821851BACKGROUNDAttaran S, Shaw M, Bond L, Pullan MD, Fabri BM. Atrial fibrillation postcardiac surgery: a common but a morbid complication. Interact Cardiovasc Thorac Surg. 2011 May;12(5):772-7. doi: 10.1510/icvts.2010.243782. Epub 2011 Feb 28.
PMID: 21357310BACKGROUNDMariscalco G, Klersy C, Zanobini M, Banach M, Ferrarese S, Borsani P, Cantore C, Biglioli P, Sala A. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation. 2008 Oct 14;118(16):1612-8. doi: 10.1161/CIRCULATIONAHA.108.777789. Epub 2008 Sep 29.
PMID: 18824644BACKGROUNDFilardo G, Hamilton C, Hebeler RF Jr, Hamman B, Grayburn P. New-onset postoperative atrial fibrillation after isolated coronary artery bypass graft surgery and long-term survival. Circ Cardiovasc Qual Outcomes. 2009 May;2(3):164-9. doi: 10.1161/CIRCOUTCOMES.108.816843. Epub 2009 Apr 24.
PMID: 20031833BACKGROUNDMathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT; Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004 Apr 14;291(14):1720-9. doi: 10.1001/jama.291.14.1720.
PMID: 15082699BACKGROUNDPerrier S, Meyer N, Hoang Minh T, Announe T, Bentz J, Billaud P, Mommerot A, Mazzucotelli JP, Kindo M. Predictors of Atrial Fibrillation After Coronary Artery Bypass Grafting: A Bayesian Analysis. Ann Thorac Surg. 2017 Jan;103(1):92-97. doi: 10.1016/j.athoracsur.2016.05.115. Epub 2016 Aug 28.
PMID: 27577036BACKGROUNDRousou JA, Meeran MK, Engelman RM, Breyer RH, Lemeshow S. Does the type of venous drainage or cardioplegia affect postoperative conduction and atrial arrhythmias? Circulation. 1985 Sep;72(3 Pt 2):II259-63.
PMID: 3875436BACKGROUNDMaisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001 Dec 18;135(12):1061-73. doi: 10.7326/0003-4819-135-12-200112180-00010.
PMID: 11747385BACKGROUNDHaissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998 Sep 3;339(10):659-66. doi: 10.1056/NEJM199809033391003.
PMID: 9725923BACKGROUNDSchotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011 Jan;91(1):265-325. doi: 10.1152/physrev.00031.2009.
PMID: 21248168BACKGROUNDCrystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003611. doi: 10.1002/14651858.CD003611.pub2.
PMID: 15495059BACKGROUNDBoos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006 Jan;27(2):136-49. doi: 10.1093/eurheartj/ehi645. Epub 2005 Nov 8.
PMID: 16278230BACKGROUNDMathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, Browner WS. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA. 1996 Jul 24-31;276(4):300-6.
PMID: 8656542BACKGROUNDAmar D, Shi W, Hogue CW Jr, Zhang H, Passman RS, Thomas B, Bach PB, Damiano R, Thaler HT. Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. J Am Coll Cardiol. 2004 Sep 15;44(6):1248-53. doi: 10.1016/j.jacc.2004.05.078.
PMID: 15364327BACKGROUNDChua SK, Shyu KG, Lu MJ, Lien LM, Lin CH, Chao HH, Lo HM. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery. J Thorac Cardiovasc Surg. 2013 Oct;146(4):919-926.e1. doi: 10.1016/j.jtcvs.2013.03.040. Epub 2013 Apr 26.
PMID: 23628495BACKGROUNDKhan AM, Lubitz SA, Sullivan LM, Sun JX, Levy D, Vasan RS, Magnani JW, Ellinor PT, Benjamin EJ, Wang TJ. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2013 Jan 1;127(1):33-8. doi: 10.1161/CIRCULATIONAHA.111.082511. Epub 2012 Nov 21.
PMID: 23172839BACKGROUNDZaman AG, Archbold RA, Helft G, Paul EA, Curzen NP, Mills PG. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation. 2000 Mar 28;101(12):1403-8. doi: 10.1161/01.cir.101.12.1403.
PMID: 10736284BACKGROUNDBooth JV, Phillips-Bute B, McCants CB, Podgoreanu MV, Smith PK, Mathew JP, Newman MF. Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery. Am Heart J. 2003 Jun;145(6):1108-13. doi: 10.1016/S0002-8703(03)00077-2.
PMID: 12796771BACKGROUNDFairley JL, Zhang L, Glassford NJ, Bellomo R. Magnesium status and magnesium therapy in cardiac surgery: A systematic review and meta-analysis focusing on arrhythmia prevention. J Crit Care. 2017 Dec;42:69-77. doi: 10.1016/j.jcrc.2017.05.038. Epub 2017 Jun 21.
PMID: 28688240BACKGROUNDLancaster TS, Schill MR, Greenberg JW, Moon MR, Schuessler RB, Damiano RJ Jr, Melby SJ. Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis. Ann Thorac Surg. 2016 Oct;102(4):1181-8. doi: 10.1016/j.athoracsur.2016.06.066. Epub 2016 Sep 2.
PMID: 27596917BACKGROUNDCook RC, Yamashita MH, Kearns M, Ramanathan K, Gin K, Humphries KH. Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg. 2013 Feb;95(2):533-41. doi: 10.1016/j.athoracsur.2012.09.008. Epub 2012 Nov 7.
PMID: 23141526BACKGROUNDKalus JS, Caron MF, White CM, Mather JF, Gallagher R, Boden WE, Kluger J. Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol. 2004 Dec 1;94(11):1423-5. doi: 10.1016/j.amjcard.2004.08.017.
PMID: 15566917BACKGROUNDMatsuura K, Ogino H, Matsuda H, Minatoya K, Sasaki H, Yagihara T, Kitamura S. Impact of volume status on the incidence of atrial fibrillation following aortic arch repair. Heart Vessels. 2007 Jan;22(1):21-4. doi: 10.1007/s00380-006-0928-y. Epub 2007 Jan 26.
PMID: 17285441BACKGROUNDPanesar SS, Athanasiou T, Nair S, Rao C, Jones C, Nicolaou M, Darzi A. Early outcomes in the elderly: a meta-analysis of 4921 patients undergoing coronary artery bypass grafting--comparison between off-pump and on-pump techniques. Heart. 2006 Dec;92(12):1808-16. doi: 10.1136/hrt.2006.088450. Epub 2006 Jun 14.
PMID: 16775087BACKGROUNDTchervenkov CI, Wynands JE, Symes JF, Malcolm ID, Dobell AR, Morin JE. Persistent atrial activity during cardioplegic arrest: a possible factor in the etiology of postoperative supraventricular tachyarrhythmias. Ann Thorac Surg. 1983 Oct;36(4):437-43. doi: 10.1016/s0003-4975(10)60484-5.
PMID: 6605126BACKGROUNDRosenfeldt FL, Watson DA. II. Interference with local myocardial cooling by heat gain during aortic cross-clamping. Ann Thorac Surg. 1979 Jan;27(1):13-6. doi: 10.1016/s0003-4975(10)62964-5.
PMID: 453953BACKGROUNDBennett EV Jr, Fewel JG, Grover FL, Trinkle JK. Myocardial preservation: effect of venous drainage. Ann Thorac Surg. 1983 Aug;36(2):132-42. doi: 10.1016/s0003-4975(10)60446-8.
PMID: 6882072BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-François Morin, MD,FRCSC
Jewish General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patient will be blinded with regards to type of venous cannulation performed intra-operatively. Measurement of outcome will be performed by an independent cardiologist, who is blinded to treatment allocation.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Surgical director, Division of Cardiac and Vascular surgery and Cardiology
Study Record Dates
First Submitted
November 11, 2020
First Posted
November 24, 2020
Study Start
July 1, 2022
Primary Completion
February 1, 2024
Study Completion
March 1, 2024
Last Updated
April 9, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share